Aroa Biosurgery Limited (ARX.AX)

0,5000 +0,0150 (+3,09%) Börsenschluss: 03:32PM AEST

Aroa Biosurgery Limited

64 Richard Pearse Drive
Airport Oaks Mangere
Auckland 2022
New Zealand
64 9 869 3035
https://aroabio.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Brian Ward	Founder, CEO, MD & Executive Director	665,87k	N/A	N/A
Mr. James Agnew BCom, LLB	CFO & Joint Company Secretary	346,58k	N/A	N/A
Mr. Scott Sherriff B.A., M.B.A.	Chief Operating Officer	N/A	N/A	N/A
Dr. Barnaby C.H. May Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Ms. Neetha Alex-Kumar	General Counsel	N/A	N/A	N/A
Mr. Frazer Murray	Director of Global Marketing & Strategy	N/A	N/A	N/A
Ms. Yasmin Winchester B.Sc.	Vice President of Quality, Regulatory & Sustainability	N/A	N/A	N/A
Ms. Tracy Weimar BA, MBA	Joint Company Secretary	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Corporate Governance

Aroa Biosurgery Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.